Jun 01, 2022 (PRNewswire via COMTEX) -- PR Newswire
DUBLIN, June 1, 2022
DUBLIN, June 1, 2022 /PRNewswire/ -- Alkermes plc /zigman2/quotes/205084517/composite ALKS -0.59% announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 2:30 p.m. ET (7:30 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com .
Contact:
Alex Braun
Investor Relations
+1 781 296 8493
SOURCE Alkermes plc
COMTEX_408063766/2454/2022-06-01T16:00:06
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.
Copyright (C) 2022 PR Newswire. All rights reserved
Add to watchlist
ALKS
